Matthew Hashem, President & CFO
President & Chief Financial Officer
Matt Hashem joined MDVIP in 2005 to oversee all aspects of the company’s finance and accounting operations. Today, as President and CFO, Mr. Hashem is responsible for both the financial stewardship of MDVIP, as well as leading the execution of the organization’s strategic plan to achieve goals that support affiliated physicians and patients nationally.
In 2006, Mr. Hashem played a key role in Procter & Gamble’s investment in MDVIP, which culminated in the full sale of the company to P&G in 2009. He remained in financial leadership during the five years P&G owned and operated MDVIP as a standalone entity, and he led the subsequent sale of MDVIP from P&G to Summit Partners in 2014. Prior to MDVIP, Mr. Hashem held several senior financial management positions in the biotechnology, software, and high-technology hardware fields with start-up growth companies backed by various venture capital funds. His previous roles include the Director of Finance at the biotechnology company U.S. Genomics headquartered in Massachusetts, and six years at KPMG as an Audit Manager.
Mr. Hashem is a cum laude graduate from the business school at the University of Massachusetts at Amherst with a degree in accounting. He has been a Certified Public Accountant since 1997.